Mark J. Cziraky
- Family Practice top 1%
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 7
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Diabetes Treatment and Management 11
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life 43
- Pharmaceutical Economics and Policy 14
-
- Acute Myocardial Infarction Research 7
-
- Lipoproteins and Cardiovascular Health 33
-
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- James M. McKenneyBenjamin M. BlumlVincent J. WilleyTerry A. JacobsonKarol E. WatsonRobert L. TalbertJerome D. CohenPeter P. Tóth
- Journals
- Circulation (2 papers)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Mark J. Cziraky
88 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Family Practice 202
- Geriatrics and Gerontology 317
- Endocrinology, Diabetes and Metabolism 482
- Economics and Econometrics 533
- Cardiology and Cardiovascular Medicine 432
Countries citing papers authored by Mark J. Cziraky
This map shows the geographic impact of Mark J. Cziraky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Cziraky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Cziraky more than expected).
Fields of papers citing papers by Mark J. Cziraky
This network shows the impact of papers produced by Mark J. Cziraky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Cziraky. The network helps show where Mark J. Cziraky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark J. Cziraky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 15 | |
| 4 | 2016 | 9 | |
| 5 | 2014 | 48 | |
| 6 | 2013 | 1 | |
| 7 | 2013 | 5 | |
| 8 | 2013 | 21 | |
| 9 | 2013 | 4 | |
| 10 | 2013 | 2 | |
| 11 | 2012 | 72 | |
| 12 | 2011 | 29 | |
| 13 | 2010 | 16 | |
| 14 | 2010 | 123 | |
| 15 | Burden of Alzheimer's disease and association with negative health outcomes. | 2009 | 42 |
| 16 | 2009 | 26 | |
| 17 | 2009 | 3 | |
| 18 | 2008 | 15 | |
| 19 | 2008 | 6 | |
| 20 | 2004 | 16 |
About Mark J. Cziraky
Mark J. Cziraky is a scholar working on Family Practice, Geriatrics and Gerontology and Economics and Econometrics, having authored 91 papers that have together received 2.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Lipoproteins and Cardiovascular Health (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Pharmaceutical Economics and Policy (14 papers), Diabetes Treatment and Management (11 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Acute Myocardial Infarction Research (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Family Practice (202 citations), Geriatrics and Gerontology (317 citations) and Endocrinology, Diabetes and Metabolism (482 citations). Mark J. Cziraky has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include James M. McKenney, Benjamin M. Bluml, Vincent J. Willey, Terry A. Jacobson, Karol E. Watson, Robert L. Talbert, Jerome D. Cohen, Peter P. Tóth, Ralph Quimbo and James P. Guevara. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.